Some folks really missed the ZAMA train earlier this year, and now they're throwing shade at the token instead of owning it. The irony? These same people dropped serious money buying MONAD when it was valued at $2B—clearly betting on hype-driven opportunities. The gap between their ZAMA skepticism and MONAD enthusiasm tells you everything about retail investor sentiment: they'd rather chase the new narrative than admit they were late to the party. Classic move when positions don't go as planned.